Gene · 7225
Papers2,972
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,972
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating genome-wide association studies and transcriptomics prioritizes drug targets for meningioma. | Brain Commun | 2025 | 40046334 | PubTator, text mining | PubMed |
| Rhotekin-1 is a novel interacting protein and regulator of TRPC6 activity. | FEBS J | 2025 | 40025790 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line (NCKDi006-A) from a 34-year-old patient with focal segmental glomerulosclerosis carrying a heterozygous mutation in the TRPC6 gene. | Stem Cell Res | 2025 | 39999713 | PubTator, text mining | PubMed |
| PIEZO1-Mediated Calcium Signaling and Podocyte Injury in Diabetic Kidney Disease. | J Am Soc Nephrol | 2025 | 39932793 | PubTator, text mining | PubMed |
| TRPC6 suppresses liver fibrosis by inhibiting hepatic stellate cell activation via CaMK4-CREB pathway. | Br J Pharmacol | 2025 | 39887689 | PubTator, text mining | PubMed |
| Genotype-Phenotype Correlations with TRPC6-Associated Podocytopathy. | J Am Soc Nephrol | 2025 | 39774909 | PubTator, text mining | PubMed |
| Corrigendum to "Chronic hypoxia promotes pulmonary venous smooth muscle cell proliferation through the CaSR-TRPC6/ROCE pathway" [Exp. Cell Res. 2024 Dec 3;444(2):114363. doi: 10.1016/j.yexcr]. | Exp Cell Res | 2025 | 39746829 | PubTator, text mining | PubMed |
| Distribution of TRPC1, TRPC3, and TRPC6 in the human thyroid. | Pathol Res Pract | 2025 | 39740284 | PubTator, text mining | PubMed |
| Evaluation of immunohistochemical TRPC3 and TRPC6 expression patterns in human endometriosis. | Ann Anat | 2025 | 39689787 | PubTator, text mining | PubMed |
| The role of TRP channels in lung fibrosis: Mechanisms and therapeutic potential. | Int J Biochem Cell Biol | 2025 | 39672503 | PubTator, text mining | PubMed |
| TRPC6 Channel Regulates Airway Remodeling in Chronic Obstructive Pulmonary Disease Causing Right Heart Failure. | Antioxid Redox Signal | 2025 | 39632592 | PubTator, text mining | PubMed |
| Discovery of a potent and selective TRPC3 antagonist with neuroprotective effects. | Bioorg Med Chem | 2025 | 39612770 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channels in Vascular Mechanotransduction. | Am J Hypertens | 2025 | 39579078 | PubTator, text mining | PubMed |
| Deficiency of endothelial TRPV4 cation channels ameliorates experimental abdominal aortic aneurysm. | Eur J Pharmacol | 2025 | 39577553 | PubTator, text mining | PubMed |
| Molecular signaling pathways in doxorubicin-induced nephrotoxicity and potential therapeutic agents. | Int Immunopharmacol | 2025 | 39566381 | PubTator, text mining | PubMed |
| Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells. | J Gastroenterol Hepatol | 2025 | 39511967 | PubTator, text mining | PubMed |
| Tinglu Yixin granule inhibited fibroblast-myofibroblast transdifferentiation to ameliorate myocardial fibrosis in diabetic mice. | J Ethnopharmacol | 2025 | 39454704 | PubTator, text mining | PubMed |
| Natural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy. | J Am Soc Nephrol | 2025 | 39352759 | PubTator, text mining | PubMed |
| Effective calcineurin inhibitor treatment in adult-onset steroid-resistant nephrotic syndrome with a novel splice donor site variant of TRPC6: a case report. | CEN Case Rep | 2025 | 39349897 | PubTator, text mining | PubMed |
| Podocyte-Specific Expression of the Stress Response Protein REDD1 Is Necessary for Diabetes-Induced Podocytopenia. | Diabetes | 2025 | 39320924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7225/papers?page=6